Swedish Pharmaceuticals & Biotech Most Popular Stocks

Newbury Pharmaceuticals

Market Cap: SEK 75.4m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Spago Nanomedical

Market Cap: SEK 69.5m

A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.

AcouSort

Market Cap: SEK 67.5m

A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.

Sprint Bioscience

Market Cap: SEK 59.1m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Genetic Analysis

Market Cap: NOK 60.8m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Modus Therapeutics Holding

Market Cap: SEK 53.4m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.

ExpreS2ion Biotech Holding

Market Cap: SEK 45.2m

A biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally.

Respiratorius

Market Cap: SEK 39.4m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Attana

Market Cap: SEK 32.6m

Provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia.

Novakand Pharma

Market Cap: SEK 31.0m

Develops drugs for inflammatory diseases and cancer in Sweden and internationally.

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs for the treatment of cancer.

ODI Pharma

Market Cap: SEK 27.3m

A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.

Spermosens

Market Cap: SEK 24.1m

Provides diagnostic health care products and services in Sweden.

Aptahem

Market Cap: SEK 22.8m

A biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions.

Level Bio

Market Cap: SEK 22.2m

Manufactures and distributes cutting-edge solutions in the Nordic region and internationally.

Prostatype Genomics

Market Cap: SEK 21.4m

Prostatype Genomics AB manufactures, markets, and sells prognostic gene tests.

Stayble Therapeutics

Market Cap: SEK 15.7m

Develops injectable treatment for chronic pain triggered by disc degeneration.

Nidhogg Resources Holding

Market Cap: SEK 13.8m

Operates in the natural resources sector primarily in Sweden.

PExA

Market Cap: SEK 13.4m

Develops and commercializes diagnostic products in various respiratory diseases.

PharmaLundensis

Market Cap: SEK 15.3m

PharmaLundensis AB operates as a pharmaceutical company.

Diagonal Bio

Market Cap: SEK 13.1m

Operates as a biotechnology company in Sweden.

Double Bond Pharmaceutical International

Market Cap: SEK 12.9m

A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.

Magnasense

Market Cap: SEK 12.1m

Develops and commercializes diagnostic tests for monitoring and optimizing the dosage of biological drugs.

LIDDS

Market Cap: SEK 9.5m

A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.

Gabather

Market Cap: SEK 8.5m

A pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases.

Quia Pharma

Market Cap: SEK 7.7m

Engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform.

DanCann Pharma

Market Cap: DKK 2.5m

A biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas.